title: TRAIL and TRAIL receptors in patients with laryngeal cancer.
abstract: Tumor necrosis factor-related associated-inducing ligand (TRAIL) is a death ligand currently under clinical trials for laryngeal carcinoma.
  
  
  
  Paraffin-embedded tissues from 40 patients with laryngeal carcinoma and 20 patients with benign laryngeal pathologies were retrospectively analyzed using immunohistochemistry in terms of distribution and intensity, and for final analysis of immunoreactivity of receptors, H-score was used. The study group was assessed in terms of localization, lymph node staging, tumor stage, overall survival, disease-free survival, locoregional control, perineural invasion, and vascular invasion.
  
  
  
  The H-score of decoy-R2 (DcR2) staining were increased significantly in tumor tissue (p = .04). A significantly greater increase in terms of H-score of DR5 receptor staining (p = .06) was detected in tumor tissue.
  
  
  
  TRAIL-mediated gene therapy may not be effective. Indeed, the findings may indicate treatment resistance. TRAIL and TRAIL receptor levels were not associated with prognosis © 2015 Wiley Periodicals, Inc. Head Neck 38: E535-E541, 2016.
authors: Department of Otorhinolaryngology, Gülhane Military Medical Academy Haydarpasa Training Hospital, Istanbul, Turkey.
authors: Evren
authors: E
authors: Erkul
authors: Department of Pathology, Gülhane Military Medical Academy Haydarpasa Training Hospital, Istanbul, Turkey.
authors: Zafer
authors: Z
authors: Kucukodaci
authors: Department of Otorhinolaryngology, Gülhane Military Medical Academy Haydarpasa Training Hospital, Istanbul, Turkey.
authors: Dogan
authors: D
authors: Pinar
authors: Department of Otorhinolaryngology, Gülhane Military Medical Academy Haydarpasa Training Hospital, Istanbul, Turkey.
authors: Atila
authors: A
authors: Gungor
authors: Department of Public Health, Gülhane Military Medical Academy, Ankara, Turkey.
authors: Mustafa
authors: M
authors: Alparslan Babayigit
authors: Department of Otorhinolaryngology, Gülhane Military Medical Academy Haydarpasa Training Hospital, Istanbul, Turkey.
authors: Onuralp
authors: O
authors: Kurt
authors: Department of Otorhinolaryngology, Gülhane Military Medical Academy Haydarpasa Training Hospital, Istanbul, Turkey.
authors: Hakan
authors: H
authors: Cincik
mesh_terms: D000328:Adult; D000368:Aged; D017209:Apoptosis; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007822:Laryngeal Neoplasms / Q000175:diagnosis / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand / Q000378:metabolism*; D012189:Retrospective Studies; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000378:metabolism*; D053319:Tumor Necrosis Factor Decoy Receptors / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha
chemical_list: D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand; D053221:TNF-Related Apoptosis-Inducing Ligand; C505639:TNFRSF10B protein, human; C451501:TNFRSF10D protein, human; C505653:TNFSF10 protein, human; D053319:Tumor Necrosis Factor Decoy Receptors; D014409:Tumor Necrosis Factor-alpha
keywords: apoptosis; larynx; receptors; squamous cell carcinoma; tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)